Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Comorbidities in social phobia

Y Lecrubier1, E Weiller

  • 1Hôpital Pitié-Salpêtrière, Paris, France.

International Clinical Psychopharmacology
|February 18, 1998
PubMed
Summary
This summary is machine-generated.

Social phobia is a prevalent condition affecting over 5% of primary care patients, often comorbid with depression and agoraphobia. Early detection and treatment are crucial due to its significant disability and underdiagnosis.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Improved ability to identify symptoms of major depressive disorder (MDD) in general practice.

International journal of psychiatry in clinical practice·2014
Same author

Recurrent brief depression: A frequent syndrome in clinical practice.

International journal of psychiatry in clinical practice·2014
Same author

DSM-5 mixed specifier for manic episodes: evaluating the effect of depressive features on severity and treatment outcome using asenapine clinical trial data.

Journal of affective disorders·2013
Same author

Effect of asenapine on manic and depressive symptoms in bipolar I patients with mixed episodes: results from post hoc analyses.

Journal of affective disorders·2012
Same author

Baseline anxiety effect on outcome of SSRI treatment in patients with severe depression: escitalopram vs paroxetine.

Current medical research and opinion·2010
Same author

The impulsivity rating scale (IRS): preliminary results.

European psychiatry : the journal of the Association of European Psychiatrists·2009
Same journal

Critical reassessment of manic and psychotic episodes related to levetiracetam: a systematic review of published case reports.

International clinical psychopharmacology·2026
Same journal

Expanding the horizon of brexpiprazole augmentation in treatment-resistant disorders: from obsessive-compulsive disorder to adolescent bipolar disorder.

International clinical psychopharmacology·2026
Same journal

Acceptability-adjusted speed in psychotic agitation: interpreting pro re nata antipsychotic data in real-world care (commentary on Hatta et al.).

International clinical psychopharmacology·2026
Same journal

Antipsychotics in clinical practice: agitation, polypharmacy, and treatment resistance.

International clinical psychopharmacology·2026
Same journal

Methylphenidate treatment in adults with comorbid attention-deficit/hyperactivity disorder and borderline personality disorder: a prospective longitudinal study.

International clinical psychopharmacology·2026
Same journal

Association between anxious depression and clinical outcomes in subjects with treatment-resistant depression: a comparative effectiveness research trial for antidepressant incomplete and non-responders with treatment-resistant depression (ASCERTAIN-TRD).

International clinical psychopharmacology·2026
See all related articles

Area of Science:

  • Psychiatry
  • General Practice
  • Epidemiology

Background:

  • Social phobia is a prevalent mental health disorder in primary care settings.
  • Comorbidities and diagnostic challenges impact patient outcomes.

Purpose of the Study:

  • To investigate the prevalence of social phobia in primary care patients.
  • To examine common comorbidities and diagnostic accuracy in general practice.

Main Methods:

  • A cross-sectional study of 2096 primary care patients in the Paris region.
  • Data collection included diagnostic interviews and assessment of comorbidities.

Main Results:

  • Social phobia prevalence was 5.1%.
  • High comorbidity with depressive episode (70% in early-onset cases) and agoraphobia (OR 10.4).

Related Experiment Videos

  • Physician recognition of social phobia was higher when depression was present (76% vs. 46%).

    • Conclusions:

    • Social phobia is common in primary care and frequently comorbid, particularly with depression.
    • Improved physician and patient education is needed for better recognition and treatment of social phobia.